menu
    • menu

    Company profile for Vasomune Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vasomune Therapeutics, Inc. is a private early stage biopharmaceutical company developing the next generation of medicines to harness the body’s ability to defend against illness. The company is transitioning in the near term to the clinic with a novel therapeutic approach to COVID-19 that involves targeting a signaling molecule in the vasculature responsible for regulating barrier defense and promoting endothelial stability...
    Vasomune Therapeutics, Inc. is a private early stage biopharmaceutical company developing the next generation of medicines to harness the body’s ability to defend against illness. The company is transitioning in the near term to the clinic with a novel therapeutic approach to COVID-19 that involves targeting a signaling molecule in the vasculature responsible for regulating barrier defense and promoting endothelial stability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vasomune TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    180 John Street, Suite 305 Toronto, ON M5T 1X5
    Telephone
    Telephone
    647 475 5660
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vasomune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vasomune, AnGes Expand Deal to More Indications
    Vasomune, AnGes Expand Deal to More Indications

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125442667/en/Vasomune-Therapeutics-Inc.-and-AnGes-Inc.-Expand-the-Scope-of-the-Co-Development-Agreement-to-Target-Additional-Indications

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Health Canada Approves Brain Injury Drug Study in Dialysis
    Health Canada Approves Brain Injury Drug Study in Dialysis

    03 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903260790/en/Health-Canada-Gives-Green-Light-to-New-Study-Investigating-Novel-Made-In-Canada-Drug-Candidate-to-Prevent-Brain-Injury-in-Hemodialysis-Patients

    BUSINESSWIRE
    03 Sep 2025
    Share Share
    Vasomune Therapeutics Presentation at ATSI Conference
    Vasomune Therapeutics Presentation at ATSI Conference

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506341317/en/Vasomune-Therapeutics-Announces-Poster-Presentation-at-the-American-Thoracic-Society-International-Conference

    BUSINESSWIRE
    06 May 2025
    Share Share
    Vasomune’s AV-001 Gets IDSMB Approval for Phase 2a Study
    Vasomune’s AV-001 Gets IDSMB Approval for Phase 2a Study

    03 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241203571729/en

    BUSINESSWIRE
    03 Dec 2024
    Share Share
    Vasomune: FDA Fast Track For Investigational Medicine AV-001
    Vasomune: FDA Fast Track For Investigational Medicine AV-001

    28 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528034965/en

    BUSINESSWIRE
    28 May 2024
    Share Share
    Vasomune Announces Poster Presentation at the ATS International Conference
    Vasomune Announces Poster Presentation at the ATS International Conference

    06 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240506279014/en

    BUSINESSWIRE
    06 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search